Who is the manufacturer of CarnaLife Holo?

Medapp S.A. filed the 510(k) submission for CarnaLife Holo (K221870).

What is the FDA product code for CarnaLife Holo?

LLZ. It is classified under 21 CFR 892.2050 as a Class 2 device in the Radiology panel.

What is the regulatory pathway for CarnaLife Holo?

510(k) clearance (submission type: Traditional).

Who can help prepare an FDA 510(k) submission like CarnaLife Holo?

Innolitics — a medical-device software consultancy — provides regulatory and engineering support for FDA 510(k) submissions. See https://innolitics.com/services/510ks/ or contact https://innolitics.com/contact.

CarnaLife Holo

K221870 · Medapp S.A. · LLZ · May 1, 2023 · Radiology

Device Facts

Record ID	K221870
Device Name	CarnaLife Holo
Applicant	Medapp S.A.
Product Code	LLZ · Radiology
Decision Date	May 1, 2023
Decision	SESE
Submission Type	Traditional
Regulation	21 CFR 892.2050
Device Class	Class 2
Attributes	Software as a Medical Device

Intended Use

CarnaLife® Holo is a software device for display of medical images and other healthcare data. It includes functions for image review, image manipulation, basic measurements, annotations, and 3D visualization. Lossy compressed mammography images and digitized film screen images must not be reviewed for primary image interpretations. Mammographic images may only be interpreted using an FDA-cleared display that meets technical specifications reviewed and accepted by FDA or displays accepted by the appropriate regulatory agency for the country in which it is used. Display monitors used for reading medical images for diagnostic purposes must comply with the applicable regulatory approvals and quality control requirements for their use and maintenance. CarnaLife® Holo software is indicated for use by qualified healthcare professionals including, but not restricted to radiologists, non-radiology specialists, physicians, and technicians. When accessing CarnaLife® Holo software from a wireless stereoscopic head-mounted display (HMD), images viewed are for informational purposes only and not intended for diagnostic use.

Device Story

CarnaLife® Holo is a SaMD for 3D visualization of DICOM medical images (CT, angio CT, MR, 4D MR, 3DRA, ECHO, PET, USG). It transforms 2D/3D DICOM data into volume and surface renderings for surgical planning. Used in operating rooms, hospitals, or remote locations; operated by radiologists, physicians, and technicians. Output viewed on desktop monitors (diagnostic) or wireless stereoscopic HMDs (informational only). Desktop interaction via mouse/keyboard; HMD interaction via hand gestures, voice commands, and virtual menus. Provides clinicians with 3D spatial context for surgical planning; aids in anatomical assessment and measurement. Benefits include enhanced visualization of patient-specific anatomy.

Clinical Evidence

Bench testing only. Verification and validation activities confirmed design outputs met input requirements. Performance testing included measurement accuracy (distance/angles) using isotropic and anisotropic voxel datasets, and volume rendering accuracy using geometric objects of known dimensions. Human factors testing conducted per ANSI/AAMI/IEC 62366.

Technological Characteristics

SaMD for 3D DICOM visualization. Supports CT, angio CT, MR, 4D MR, 3DRA, ECHO, PET, USG. Features volume/surface rendering, MPR, and measurement tools. Connectivity: Local workstation or wireless HMD. Security: HTTPS/SSL encryption, local storage, audit trails. Software-based image processing.

Indications for Use

Indicated for qualified healthcare professionals (radiologists, non-radiology specialists, physicians, technicians) for display, review, manipulation, measurement, annotation, and 3D visualization of medical images. Not for primary interpretation of lossy compressed mammography or digitized film screen images. HMD use is for informational purposes only, not diagnostic.

Regulatory Classification

Identification

A medical image management and processing system is a device that provides one or more capabilities relating to the review and digital processing of medical images for the purposes of interpretation by a trained practitioner of disease detection, diagnosis, or patient management. The software components may provide advanced or complex image processing functions for image manipulation, enhancement, or quantification that are intended for use in the interpretation and analysis of medical images. Advanced image manipulation functions may include image segmentation, multimodality image registration, or 3D visualization. Complex quantitative functions may include semi-automated measurements or time-series measurements.

Special Controls

*Classification.* Class II (special controls; voluntary standards—Digital Imaging and Communications in Medicine (DICOM) Std., Joint Photographic Experts Group (JPEG) Std., Society of Motion Picture and Television Engineers (SMPTE) Test Pattern).

Predicate Devices

SurgicalAR (K190764)

Related Devices

K190764 — SurgicalAR · Medivis, Inc. · May 13, 2019
K230249 — Ikshana · Immersivetouch · Oct 16, 2023
K142107 — ECHO TRUE 3D VIEWER · Echopixel, Inc. · Jan 21, 2015
K221796 — Cyware 4H and Cysart 4H · Abys Medical · Dec 30, 2022
K243933 — Ceevra Reveal 3+ · Ceevra, Inc. · Mar 4, 2025

Submission Summary (Full Text)

{0}------------------------------------------------ Image /page/0/Picture/0 description: The image contains the logo of the U.S. Food and Drug Administration (FDA). The logo consists of two parts: the Department of Health & Human Services logo on the left and the FDA logo on the right. The FDA logo features the letters "FDA" in a blue square, followed by the words "U.S. FOOD & DRUG ADMINISTRATION" in blue text. MedApp S.A. % Albert Pacheco Alliance Network Independent Consultant PAREXEL International 8 Federal Street BILLERICA, MASSACHUSETTS 01821 May 1, 2023 Re: K221870 Trade/Device Name: CarnaLife® Holo Regulation Number: 21 CFR 892.2050 Regulation Name: Medical Image Management And Processing System Regulatory Class: Class II Product Code: LLZ Dated: March 21, 2023 Received: March 22, 2023 Dear Albert Pacheco: We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database located at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading. If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's {1}------------------------------------------------ requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR 803) for devices or postmarketing safety reporting (21 CFR 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reportingcombination-products); good manufacturing practice requirements as set forth in the quality systems (OS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-device-safety/medical-device-reportingmdr-how-report-medical-device-problems. For comprehensive regulatory information about mediation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medicaldevices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-device-advice-comprehensive-regulatoryassistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100). Sincerely, Jessica Lamb Jessica Lamb, Assistant Director Imaging Software Team DHT8B: Division of Radiological Imaging Devices and Electronic Products OHT8: Office of Radiological Health Office of Product Evaluation and Quality Center for Devices and Radiological Health Enclosure {2}------------------------------------------------ ### Indications for Use 510(k) Number (if known) K221870 Device Name CarnaLife® Holo #### Indications for Use (Describe) CarnaLife® Holo is a software device for display of medical images and other healthcare data. It includes functions for image review, image manipulation, basic measurements, annotations, and 3D visualization. Lossy compressed mammography images and digitized film screen images must not be reviewed for primary image interpretations. Mammographic images may only be interpreted using an FDA-cleared display that meets technical specifications reviewed and accepted by FDA or displays accepted by the appropriate regulatory agency for the country in which it is used. Display monitors used for reading medical images for diagnostic purposes must comply with the applicable regulatory approvals and quality control requirements for their use and maintenance. CarnaLife® Holo software is indicated for use by qualified healthcare professionals including, but not restricted to radiologists, non-radiology specialists, physicians, and technicians. When accessing CarnaLife® Holo software from a wireless stereoscopic head-mounted display (HMD), images viewed are for informational purposes only and not intended for diagnostic use. | Type of Use (Select one or both, as applicable) | | |-------------------------------------------------|-----------------------------------------| | Prescription Use (Part 21 CFR 801 Subpart D) | ☑ | | Over-The-Counter Use (21 CFR 801 Subpart C) | ☐ | CONTINUE ON A SEPARATE PAGE IF NEEDED. #### This section applies only to requirements of the Paperwork Reduction Act of 1995. #### *DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.* The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to: > Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov "An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number." {3}------------------------------------------------ # 510(k) Summary as Required by 21 CFR 807.92(c) ## For CarnaLife® Holo | Date Prepared: | April 26, 2023 | |------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------| | Submitter: | MedApp,S.A. Armii Krajowej 25 30-150 Kraków, Poland | | Official Contact: | Al Pacheco Independent Consultant Parexel International 2520 Meridian Parkway, Suite 200 Durham, NC 27713, USA Phone: +1 760 421 2919 Email: albert.pacheco@parexel.com | | Proprietary Name: | CarnaLife® Holo | | Classification: | Class II Medical Image Management and Processing System 21 CFR 892.2050 Product Code: LLZ | | Predicate Device: | SurgicalAR (K190764) | | Reason for Submission: | New Device | #### Device Description CarnaLife® Holo is a Software as a Medical Device (SaMD) to be used by qualified healthcare professionals including, but not restricted to radiologists, non-radiology specialists, physicians, and technicians for the visualization of medical images in 3D to allow for surgical planning activities. The device makes it possible to visualize 3D Digital Imaging and Communications in Medicine (DICOM) files using volume and surface rendering in 3D to be viewed on a classic display or on a stereoscopic, holographic display. CarnaLife® Holo is intended to be used in operating rooms; office environments within hospitals or at any other location with a computer; and for informational purposes only at any location using the head-mounted display (HMD). The images can be viewed on desktop PCs with a monitor allowing the interaction with CarnaLife® Holo to be performed with a mouse and/or keyboard; and on an HMD, where the interaction with CarnaLife® Holo is performed using hand gestures, voice commands and virtual menus. CarnaLife® Holo is used to: - Load patient DICOM data; ● - . Image review, image manipulation, basic measurements, annotations, and 3D visualization; and - . View DICOM data using a traditional computer monitor, display monitors used for reading medical images for diagnostic purposes, or in mixed reality (MR) using a head-mounted display (HMD). {4}------------------------------------------------ #### Indications for Use CarnaLife® Holo is a software device for display of medical images and other healthcare data. It includes functions for image review, image manipulation, basic measurements, annotations, and 3D visualization. Lossy compressed mammography images and digitized film screen images must not be reviewed for primary image interpretations. Mammographic images may only be interpreted using an FDA-cleared display that meets technical specifications reviewed and accepted by FDA or displays accepted by the appropriate regulatory agency for the country in which it is used. Display monitors used for reading medical images for diagnostic purposes must comply with the applicable regulatory approvals and quality control requirements for their use and maintenance. CarnaLife® Holo software is indicated for use by qualified healthcare professionals including, but not restricted to radiologists, non-radiology specialists, physicians, and technicians. When accessing CarnaLife® Holo software from a wireless stereoscopic head-mounted display (HMD), images viewed are for informational purposes only and not intended for diagnostic use. #### Substantial Equivalence Discussion CarnaLife® Holo is substantially equivalent to the predicate device, SurgicalAR (K190764), as both devices have the same intended use and similar technological characteristics. While both devices do not have the same software features, the differences do not raise different questions of safety and effectiveness. | Device Characteristic | Subject Device: CarnaLife® Holo (K221870) | Predicate Device: SurgicalAR (K190764) | Comparison | |--------------------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------| | Classification | Class II | Class II | Same | | Product Code | LLZ | LLZ | Same | | Indications for Use | CarnaLife® Holo is a software device for display of medical images and other healthcare data. It includes functions for image review image manipulation, basic measurements, and 3D visualization. Lossy compressed mammography images and digitized film screen images must not be reviewed for primary image interpretations. Mammographic images may only be interpreted using an FDA- cleared display that meets technical specifications reviewed and accepted by FDA or displays accepted by the appropriate regulatory agency | SurgicalAR is a software device for display of medical images and other healthcare data. It includes functions for image review image manipulation, basic measurements, and 3D visualization (MPR reconstructions and 3D volume rendering). Lossy compressed mammography images and digitized film screen images must not be reviewed for primary image interpretations. Mammographic images may only be interpreted using an FDA- cleared display that meets technical specifications reviewed and accepted by FDA or displays accepted by the appropriate regulatory agency for the country in which it is used. | Same | | Device Characteristic | Subject Device: CarnaLife® Holo (K221870) | Predicate Device: SurgicalAR (K190764) | Comparison | | | for the country in which it is used. Display monitors used for reading medical images for diagnostic purposes must comply with the applicable regulatory approvals and quality control requirements for their use and maintenance. CarnaLife® Holo software is indicated for use by qualified healthcare professionals including, but not restricted to radiologists, non-radiology specialists, physicians, and technicians. When accessing CarnaLife® Holo software from a wireless stereoscopic head-mounted display (HMD), images viewed are for informational purposes only and not intended for diagnostic use. | Display monitors used for reading medical images for diagnostic purposes must comply with the applicable regulatory approvals and quality control requirements for their use and maintenance. SurgicalAR software is indicated for use by qualified healthcare professionals including, but not restricted to radiologists, non-radiology specialists, physicians, and technologists. When accessing SurgicalAR software from a wireless stereoscopic head-mounted display (HMD) or mobile device, images viewed are for informational purposes only and not intended for diagnostic use. | | | Prescription Use or OTC Use | Prescription use | Prescription use | Same | | Annotation and Measurement Tools | Line Angle Ruler Arrow | Line Angle Ruler Arrow | Same | | Data Type Supported | DICOM Non-DICOM | DICOM Non-DICOM | Same | | Image Input Types Supported | CT/angio CT MR/4D MR 3DRA ECHO PET USG | CT MR | Different: The difference does not alter intended use and is supported by software verification and validation. | | Image View/ Manipulation | Image Zoom/Zoom Pan Window Level AutoWindow/Presets | Image Zoom Pan Window Level AutoWindow | Different: The predicate device does | | Device Characteristic | Subject Device: CarnaLife® Holo (K221870) | Predicate Device: SurgicalAR (K190764) | Comparison | | | Level Reset Scout Lines/Intersection Lines Image Rotate Image Flipor Intersection Image Invert Magnify | Level Reset Scout Lines Image Rotate Image Flip Magnify | not have the "Image Invert" functionality. | | Data Encryption | HTTPS SSL | HTTPS SSL | Same | | Patient Demographic Display | Capable of displaying patient demographic information | Capable of displaying patient demographic information | Same | | Data Security | Stored locally on the workstation (PC) | Stored on server | Same | | Audit Trail | Audit trail logged | Audit trail logged | Same | | File Type Used | JPEG for lossy data PNG for lossless data | JPEG for lossy data PNG for lossless data | Same | | MPR Viewing | This viewing feature enables the display of reformatted CT and MR images into axial, coronal, and sagittal orientations. | This viewing feature enables the display of reformatted CT and MR images into axial, coronal, and sagittal orientations. | Same | | 3D Volume Rendered Viewing | This viewing feature enables the display of 3D perspective views of CT and MR image sets that have been transformed into volumes. It also provides presets to enable users to alter the visualization parameters of the 3D views to highlight features. | This viewing feature enables the display of 3D perspective views of CT and MR image sets that have been transformed into volumes. It also provides presets to enable users to alter the visualization parameters of the 3D views to highlight features. | Same | | Crosshair Navigation and Synchronization | This viewing feature provides a facility to synchronize and scroll through multiple views at the same time. | This viewing feature provides a facility to synchronize and scroll through multiple views at the same time. | Same | | Ability to close an image by clicking an "X" in the upper-left portion of the view port | Ability to close an image by clicking an "X" in the examination tab. | Ability to close an image by clicking an "X" in the upper-left portion of the viewport. | Same | | Support for TIF Files | Yes | Yes | Same | | Support for BMP Files | Yes | No | Different: The difference does not alter intended use and is supported by software verification | | Device Characteristic | Subject Device: CarnaLife® Holo (K221870) | Predicate Device: SurgicalAR (K190764) | Comparison | | | | | and validation. | | Support of Stored ECHO Data | Yes | No | Different: The difference does not alter intended use and is supported by software verification and validation. | | HMD support for informational purposes only (not for diagnostic use) | This viewing feature provides access of CarnaLife® Holo software on consumer, off-the- shelf wireless, Wi-Fi enabled, stereoscopic head-mounted display with minimum of 2GB RAM. | This viewing feature provides access of SurgicalAR software on consumer, off-the-shelf wireless, Wi-Fi enabled, stereoscopic head- mounted display with minimum of 2GB RAM. | Same | | Diagnostic quality medical image review | Ability to provide diagnostic quality medical image review for multi-dimensional digital images acquired from a variety of imaging devices. | Ability to provide diagnostic quality medical image review for multi- dimensional digital images acquired from a variety of imaging devices. | Same | {5}------------------------------------------------ {6}------------------------------------------------ {7}------------------------------------------------ #### Performance Data Design validation and verification activities were performed for CarnaLife® Holo as a result of the risk analysis assessment and product requirements. The purpose of software design verification activities was to ensure that the design output specifications met the design input requirements. It is concluded that the design verification was successful in that the design output specifications satisfactorily met the design input requirements. Design validation was successfully completed, and testing met all predetermined acceptance criteria based on user needs and intended use. Human factors activities were completed per ANSI/AAMI/IEC 62366. Performance testing included: - . Accuracy of the Measuring function: This testing was conducted using two data sets characterized by different voxel sizes (isotropic and anisotropic data). For each set, points P1, P2, P3 and P4 were defined for both Axial and Coronal projections. Measurement accuracy met specified requirements for the below measurements of distance: - o X - distance of P1-P2 and P3-P4 - o Y - distance of P1-P3 and P2-P4 - Angles defined by points P1-P2-P3 o - Diagonals defined by P1-P4 and P3-P2. o {8}------------------------------------------------ - Accuracy of Volume Rendering: This testing was conducted by performing Volume Rendering on . CT scans of two different geometric objects of known size and dimensions. The accuracy of Volume Rendering meeting specified requirements was demonstrated by comparing the size and dimensions of resulting displayed holograms to the known size and dimensions of the two geometric objects. #### Conclusion The performance data demonstrate the CarnaLife® Holo is as safe, as effective, and performs as well as or better than the predicate device, SurgicalAR (K190764). In conclusion, the subject device, CarnaLife® Holo, is substantially equivalent to the predicate device, SurgicalAR (K190764).